US EditionInmedix® announces the US launch of its FDA-cleared CloudHRV™ System at the 2025 Rheumatology Winter Clinical Symposium. - Journal of Cyber Policy
Summary by EIN Presswire
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Inmedix® announces the US launch of its FDA-cleared CloudHRV™ System at the 2025 Rheumatology Winter Clinical Symposium. - Journal of Cyber Policy
Inmedix CloudHRV System Precision heart rate variability (HRV) launched first to rheumatologists. NORMANDY PARK, WA, UNITED STATES, February 23, 2025 /EINPresswire.com/ — Inmedix®, Inc. (“Inmedix”) announced the US commercial launch of its CloudHRV System diagnostic to rheumatologists at the Rheumatology Winter Clinical Symposium (RWCS) in Wailea, Maui, February 12-15, 2025. On January 17, 2025, the US FDA cleared the Inmedix CloudHRV System for…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
